Podcast 588: Esmolol for Refractory Ventricular Fibrillation
Aug 18, 2020•4 min
Episode description
Contributor: Ricky Dhaliwal, MD, JD
Educational Pearls:
- Ventricular Fibrillation (VF) is a potentially fatal cardiac arrhythmia; Refractory VF even more so
- Epinephrine stimulates alpha and beta receptors which increase sympathetic tone, thereby increasing cardiac oxygen demand and myocardial calcium levels which can cause new arrhythmias, particularly a problem during resuscitation
- Esmolol (or any beta blocker) can be used in VF refractory to defibrillation, epinephrine and amiodarone in a last-ditch effort.
- Esmolol in the setting of epinephrine can help prevent some of these known effects from repeated beta stimulation
- Dosing esmolol for refractory VF: 500mcg/kg bolus, followed by drip (max typically 1000 mcg/kg/min)
- Esmolol is associated with improved mortality in ACLS care in refractory VF
References
Long DA, Long B, April MD. Does β-Blockade for Treatment of Refractory Ventricular Fibrillation or Pulseless Ventricular Tachycardia Improve Outcomes?. Ann Emerg Med. 2020;76(1):42-45. doi:10.1016/j.annemergmed.2020.01.025
Lee YH, Lee KJ, Min YH, et al. Refractory ventricular fibrillation treated with esmolol. Resuscitation. 2016;107:150-155. doi:10.1016/j.resuscitation.2016.07.243
Summarized by Jackson Roos, MS4 | Edited by Erik Verzemnieks, MD
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast